BREATHMOR

Live / Registered — Registered (as of 03 Mar 2026)

What this means for you

Registered since 03 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97123082
Registration number
8161503
Mark type
Design + words
Filed
12 Nov 2021
Published for opposition
01 Nov 2022
Registered
03 Mar 2026
Attorney of record
Sandra Epp Ryan

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of allergic rhinitis, asthma, migraine, stress and headache; nutraceuticals for the treatment of allergic rhinitis, asthma, migraine, stress and headache; pharmaceutical preparations for the treatment and prevention of hay fever symptoms such as sneezing, nasal congestion, itchy nose, runny nose and itchy eyes; nutraceuticals for the treatment of hay fever symptoms such as sneezing, nasal congestion, itchy nose, runny nose and itchy eyes

Owner

Prosecution history

  • 03 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 03 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
  • 10 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 10 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 29 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
  • 24 Dec 2025 — USE AMENDMENT FILED
  • 24 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
  • 03 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 02 Jul 2025 — SOU EXTENSION 5 GRANTED
  • 27 Jun 2025 — SOU EXTENSION 5 FILED
  • 27 Jun 2025 — SOU TEAS EXTENSION RECEIVED
  • 08 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 07 Apr 2025 — SOU EXTENSION 4 GRANTED
  • 19 Dec 2024 — SOU EXTENSION 4 FILED
  • 07 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL

View this trademark record on Marksy